The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease.

Imagine spotting a fawn far off or, better yet, a robin’s nest high up in a tree because you have a close-up view in the palm ...

Introduction: Why the Starscope Monocular Is Gaining Popularity in 2025 Whether you're a nature lover, hiker, hunter, or ...

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

To bridge these significant gaps, this paper presents a new long-distance gaze estimation paradigm: train a camera to perform eye tracking by another eye tracker, named Learning-based Single Camera ...

We have rounded up the best night vision monoculars on the market right now and have models to suit different needs and ...

Construction of a 450-metre pedestrian skywalk, which will connect KCBT to the railway station across GST Road, is expected to resume shortly. CHENNAI: Bus commuters facing hardship in accessing ...

The news comes as welcome relief for motorists who have coped with detours through local streets in Wharton and other towns, starting in late December when a first sinkhole was identified and ...

National Vision completed the initial public offering of its common stock in October 2017. EYE is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Momentum investors should take note of this ...

National Vision completed the initial public offering of its common stock in October 2017. EYE is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of A and VGM Score of B. Shares are up ...

LOS ANGELES (KABC) -- Injury, age and poor posture can all contribute to herniated or bulging discs, which is a common cause of upper and lower back pain. Treatments range from pain management to ...